PL1663991T3 - Selektywna synteza CF3 – podstawionych pirymidyn - Google Patents

Selektywna synteza CF3 – podstawionych pirymidyn

Info

Publication number
PL1663991T3
PL1663991T3 PL04769170T PL04769170T PL1663991T3 PL 1663991 T3 PL1663991 T3 PL 1663991T3 PL 04769170 T PL04769170 T PL 04769170T PL 04769170 T PL04769170 T PL 04769170T PL 1663991 T3 PL1663991 T3 PL 1663991T3
Authority
PL
Poland
Prior art keywords
substituted pyrimidines
selective synthesis
selective
synthesis
pyrimidines
Prior art date
Application number
PL04769170T
Other languages
English (en)
Inventor
John Charles Kath
Daniel Tyler Richter
Michael Joseph Luzzio
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PL1663991T3 publication Critical patent/PL1663991T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
PL04769170T 2003-09-05 2004-08-24 Selektywna synteza CF3 – podstawionych pirymidyn PL1663991T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50073303P 2003-09-05 2003-09-05
PCT/IB2004/002744 WO2005023780A1 (en) 2003-09-05 2004-08-24 Selective synthesis of cf3-substituted pyrimidines
EP04769170A EP1663991B1 (en) 2003-09-05 2004-08-24 Selective synthesis of cf3-substituted pyrimidines

Publications (1)

Publication Number Publication Date
PL1663991T3 true PL1663991T3 (pl) 2007-04-30

Family

ID=34272990

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04769170T PL1663991T3 (pl) 2003-09-05 2004-08-24 Selektywna synteza CF3 – podstawionych pirymidyn

Country Status (23)

Country Link
US (1) US7122670B2 (pl)
EP (1) EP1663991B1 (pl)
JP (1) JP4842816B2 (pl)
KR (1) KR100694732B1 (pl)
CN (1) CN100465164C (pl)
AR (1) AR045557A1 (pl)
BR (1) BRPI0414059B8 (pl)
CA (1) CA2537373C (pl)
CO (1) CO5650237A2 (pl)
CY (1) CY1106370T1 (pl)
DE (1) DE602004004287T2 (pl)
DK (1) DK1663991T3 (pl)
ES (1) ES2276344T3 (pl)
IL (1) IL173363A (pl)
MX (1) MXPA06002552A (pl)
NO (1) NO334383B1 (pl)
NZ (1) NZ544969A (pl)
PL (1) PL1663991T3 (pl)
PT (1) PT1663991E (pl)
RU (1) RU2315759C2 (pl)
TW (1) TWI283667B (pl)
WO (1) WO2005023780A1 (pl)
ZA (1) ZA200600747B (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH072586Y2 (ja) 1988-11-25 1995-01-25 日東紡績株式会社 ガラス繊維紡糸用冷却フィン装置
MXPA06002608A (es) * 2002-12-20 2007-01-23 Pfizer Prod Inc Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
US20060205945A1 (en) * 2004-05-14 2006-09-14 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
JP4778717B2 (ja) * 2005-03-25 2011-09-21 富士フイルム株式会社 複素環式化合物の製造方法
DE102007010801A1 (de) 2007-03-02 2008-09-04 Bayer Cropscience Ag Diaminopyrimidine als Fungizide
JP4782239B2 (ja) 2007-04-18 2011-09-28 ファイザー・プロダクツ・インク 異常細胞増殖治療のためのスルホニルアミド誘導体
KR101294731B1 (ko) * 2007-06-04 2013-08-16 삼성디스플레이 주식회사 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법
UY31714A (es) 2008-03-20 2009-11-10 Boehringer Ingelheim Int Preparación selectiva de pirimidinas sustituidas
CA2718858A1 (en) 2008-03-20 2009-09-24 Boehringer Ingelheim International Gmbh Selective synthesis of substituted pyrimidines
DE102009006643A1 (de) 2009-01-29 2010-08-05 Saltigo Gmbh Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten
TW201100441A (en) 2009-06-01 2011-01-01 Osi Pharm Inc Amino pyrimidine anticancer compounds
WO2011018517A1 (en) 2009-08-14 2011-02-17 Boehringer Ingelheim International Gmbh Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
US8933227B2 (en) * 2009-08-14 2015-01-13 Boehringer Ingelheim International Gmbh Selective synthesis of functionalized pyrimidines
PT2646448T (pt) 2010-11-29 2017-10-04 Osi Pharmaceuticals Llc Inibidores macrocíclicos de cinases
UY33817A (es) 2010-12-21 2012-07-31 Boehringer Ingelheim Int ?nuevas oxindolpirimidinas bencílicas?.
JP5937112B2 (ja) 2011-02-17 2016-06-22 カンサー・セラピューティクス・シーアールシー・プロプライエタリー・リミテッドCancer Therapeutics Crc Pty Limited 選択的fak阻害剤
ES2691673T3 (es) 2011-02-17 2018-11-28 Cancer Therapeutics Crc Pty Limited Inhibidores de Fak
WO2014126954A1 (en) 2013-02-13 2014-08-21 OSI Pharmaceuticals, LLC Regioselective synthesis of substituted pyrimidines
US9656970B2 (en) 2014-05-08 2017-05-23 Tosoh F-Tech, Inc. 5-(trifluoromethyl)pyrimidine derivatives and method for producing same
JP6391985B2 (ja) * 2014-05-16 2018-09-19 東ソー・ファインケム株式会社 2−置換−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法
JP6391988B2 (ja) * 2014-05-21 2018-09-19 東ソー・ファインケム株式会社 5−(トリフルオロメチル)ピリミジン誘導体の製造方法及び新規5−(トリフルオロメチル)ピリミジン誘導体
CN108440499A (zh) * 2018-03-22 2018-08-24 盐城师范学院 一种色瑞替尼及其关键中间体的制备方法
CN114213339B (zh) * 2021-12-20 2023-10-31 苏州康纯医药科技有限公司 一种表皮细胞生长因子受体突变抑制剂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2896532B2 (ja) * 1994-08-13 1999-05-31 ユーハン コーポレーション 新規なピリミジン誘導体およびその製造方法
WO2003030909A1 (en) * 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
ES2314106T3 (es) * 2001-10-17 2009-03-16 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Derivados de pirimidina, agentes farmaceuticos que contiene dichos compuestos, uso y metodo para su obtencion.

Also Published As

Publication number Publication date
IL173363A0 (en) 2006-06-11
US7122670B2 (en) 2006-10-17
CY1106370T1 (el) 2011-10-12
IL173363A (en) 2010-05-31
TW200514773A (en) 2005-05-01
BRPI0414059B8 (pt) 2021-05-25
JP4842816B2 (ja) 2011-12-21
BRPI0414059B1 (pt) 2018-11-06
ZA200600747B (en) 2007-03-28
CN100465164C (zh) 2009-03-04
MXPA06002552A (es) 2006-06-20
US20050101620A1 (en) 2005-05-12
NZ544969A (en) 2008-07-31
DE602004004287D1 (de) 2007-02-22
KR20060030918A (ko) 2006-04-11
RU2315759C2 (ru) 2008-01-27
RU2006106727A (ru) 2006-06-27
WO2005023780A1 (en) 2005-03-17
PT1663991E (pt) 2007-02-28
NO20061509L (no) 2006-04-03
ES2276344T3 (es) 2007-06-16
AU2004270480A1 (en) 2005-03-17
JP2007504211A (ja) 2007-03-01
HK1091824A1 (zh) 2007-01-26
NO334383B1 (no) 2014-02-24
BRPI0414059A (pt) 2006-10-24
KR100694732B1 (ko) 2007-03-14
EP1663991A1 (en) 2006-06-07
EP1663991B1 (en) 2007-01-10
DE602004004287T2 (de) 2007-06-21
TWI283667B (en) 2007-07-11
AR045557A1 (es) 2005-11-02
CA2537373A1 (en) 2005-03-17
CN1845906A (zh) 2006-10-11
DK1663991T3 (da) 2007-04-10
CA2537373C (en) 2009-10-20
CO5650237A2 (es) 2006-06-30

Similar Documents

Publication Publication Date Title
IL173363A0 (en) Selective synthesis of cf3-substituted pyrimidines
AU2003213092A8 (en) Syntheses of quinazolinones
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
EP1778618A4 (en) SYNTHESIS OF TRIETHYLENETETRAMINES
IL175284A0 (en) Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
AU2003262794A8 (en) Total synthesis of heparin
EP1639121A4 (en) SYNTHESIS OF BETA-L-2-DESOXYNUCLEOSIDES
EP1711484A4 (en) SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
EP1602809A4 (en) MOUNTING CONSTRUCTION FOR THERMOSTAT
SI1663991T1 (sl) Selektivna sinteza CF3-substituiranih pirimidinov
GB0328323D0 (en) Synthesis of 2-substituted adenosines
PL375437A1 (pl) Synteza gatifloksacyny
GB0329319D0 (en) Synthesis
GB2422833B (en) Zaleplon synthesis
AU2003217354A8 (en) Synthesis of sulfamidates
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
GB0328319D0 (en) Improved synthesis of 2-substituted adenosines
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
GB0328318D0 (en) Synthesis of spongosine
TW573941U (en) Improved structure of heat sink
TW562061U (en) Structure of shaping forms
HK1086039A (en) Synthesis of beta -l-2-deoxy nucleosides
TW553243U (en) Structure of clotheshanger
SI1567522T1 (sl) Pirimidinske spojine
TW582219U (en) Improved structure of flabellum